Therapeutic targets for treating fibrotic kidney diseases
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Biochemistry, medical,Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)
Reference174 articles.
1. Cellular and molecular mechanisms of renal fibrosis;Liu;Nat Rev Nephrol,2011
2. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases;Wynn;J Clin Invest,2007
3. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes;Levey;Kidney Int,2007
4. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes;Lewis;N Engl J Med,2001
5. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy;Brenner;N Engl J Med,2001
Cited by 140 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tissue damage in lupus;Dubois' Lupus Erythematosus and Related Syndromes;2025
2. Ameliorative effect of aqueous avocado seed extract against chromium‐induced oxidative stress and cellular damage in rabbit kidney;Food Science & Nutrition;2024-05-22
3. Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets;Journal of Clinical Medicine;2024-03-25
4. Pathogenic pathways of renal damage in Fabry nephropathy: interplay between immune cell infiltration, apoptosis and fibrosis;Journal of Nephrology;2024-03-21
5. Protein and peptide-based renal targeted drug delivery systems;Journal of Controlled Release;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3